HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-chloro-2-cyclopropyl-1H-benzo[d]imidazole → (E)-2-{8-[(4-chloro-2-cyclopropyl-1H-benzo[d]imidazol-1-yl)methyl]-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene}-2-cyclopropylacetonitrile
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-chloro-2-cyclopropyl-1H-benzo[d]imidazole | HCID 60978792 | — |
| Reactant | (E)-2-(8-bromomethyl-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)-2-cyclopropylacetonitrile | HCID 86721388 | — |
| Product | (E)-2-{8-[(4-chloro-2-cyclopropyl-1H-benzo[d]imidazol-1-yl)methyl]-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene}-2-cyclopropylacetonitrile | HCID 86721390 | 74.8% |
Reaction Steps
Using 4-chloro-2-cyclopropyl-1H-benzo[d]imidazole (EP1988091, 60 mg, 0.31 mmol) and (E)-2-(8-bromomethyl-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)-2-cyclopropylacetonitrile (120 mg, 0.31 mmol) obtained in Reference Example 6, and in the same manner as in Reference Example 1A, the title compound (115 mg, 74%) was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08969345B2 |
| Source dataset | uspto-grants-2015_03 |
| ORD ID | ord-23f2afecee18464488149da6a72e37d7 |
| Source note | uspto-grants-2015_03 |